Akèy › Sklerodèm › Kansas › Kansas City
Etid klinik pou Sklerodèm nan Kansas City, KS
4 etid pou Sklerodèm ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- University of Kansas Cancer Center, Kansas City
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
- University of Kansas Medical Center, Kansas City
Etid Sklerodèm nan lòt vil
- New York City, NY11 etid
- Ann Arbor, MI10 etid
- Chicago, IL10 etid
- Houston, TX9 etid
- Boston, MA7 etid
- Durham, NC7 etid
- Los Angeles, CA7 etid
- New Orleans, LA6 etid
- Philadelphia, PA6 etid
- Baltimore, MD6 etid
- Dallas, TX5 etid
- Pittsburgh, PA5 etid
Lòt etid nan Kansas City
- Maladi kadyovaskilè14 etid
- Maladi poumon entèstisyèl13 etid
- Ensifizyans kadyak13 etid
- Obèsite13 etid
- Fibroz sistik13 etid
- Kansè vejik12 etid
- Kansè pwostat12 etid
- Kansè nan tete12 etid
- Kansè Poumon ki pa ti selil11 etid
- Leksemi mieloïd egi11 etid
- Kansè poumon11 etid
- BPCO9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.